Leveraging RNA sequencing to identify actionable biomarkers in NSCLC management
Join us in a dynamic discussion with Dr. Marc Matrana of Ochsner Health as he shares how RNA sequencing revealed new treatment options for his patient when DNA seq was unsuccessful identifying key, actionable biomarkers.
Apr 05, 2024
Providers
Webinar
Marc Matrana, MD, FACP, MSSystem Director of Precision Medicine, Ochsner Health
Gary I. Grad, MDSenior Medical Oncologist, Tempus
Ezra Cohen, MD FRCPSC, FASCOChief Medical Officer of Oncology, Tempus


